SENP1

SENP1 (PF3D7_1233900) is a catalytically active SUMO-specific cysteine protease of P. falciparum that operates in the parasite's SUMOylation cycle (PMID:21700207). Biochemical profiling of the recombinant catalytic domain with a positional scanning substrate library established it as a functional SUMO protease whose cleavage-sequence preference is distinct from that of human SENPs (PMID:21700207). In reconstituted in vitro assays, SENP1 performs both arms of SUMO metabolism: it deconjugates SUMO-1 from modified RanGAP1 (isopeptidase/deSUMOylase activity) and processes SUMO precursors to their mature form (maturation activity) (PMID:21700207). Its enzymatic activity is required for the intraerythrocytic cycle: aza-epoxide small-molecule inhibitors (most potent VEA-260) block recombinant SENP1 activity and P. falciparum replication in human erythrocytes, with parasite clearance tracking inhibitor potency, and the most potent compound disrupts late schizont morphology and prevents egress from the red blood cell (PMID:21700207). In P. berghei, proximity labeling places SENP1 in the vicinity of the nuclear pore complex (PMID:36040030). Beyond these findings, the direct substrates, structural basis, and genetic loss-of-function phenotype of SENP1 have not been characterized in the available corpus.

1. 2009 Low

   Before mechanistic work could proceed, it was unknown whether SENP1 could be produced as folded, homogeneous protein; establishing a purification route enabled all downstream biochemistry.

   Evidence Recombinant expression in E. coli via a CPD-His6 fusion tag, affinity and gel-filtration purification, and growth of diffraction-quality crystals

   PMID:19956581

   Open questions at the time

   • No crystal structure was reported despite diffraction-quality crystals
   • Purification demonstrates feasibility but establishes no catalytic or biological function
2. 2011 High

   It was unknown whether SENP1 is a genuine SUMO protease and how its specificity compares to human enzymes; profiling defined it as a functional SUMO-specific protease with a unique cleavage preference, marking it as biochemically distinct from human SENPs.

   Evidence Recombinant catalytic domain assayed with a positional scanning substrate library (in vitro)

   PMID:21700207

   Open questions at the time

   • Distinct specificity does not identify the endogenous parasite substrates
   • Assay used a synthetic library rather than native Plasmodium SUMO conjugates
3. 2011 High

   To confirm SENP1 carries out canonical SUMO-cycle chemistry, both its deconjugating and precursor-maturation activities were tested; it cleaved SUMO-1 from RanGAP1 and processed SUMO precursors, establishing dual deSUMOylase and maturation functions.

   Evidence In vitro deSUMOylation assay with recombinant catalytic domain against SUMO-RanGAP1 and SUMO precursor substrates

   PMID:21700207

   Open questions at the time

   • Activities shown on human SUMO-1/RanGAP1 substrates, not native Plasmodium SUMO conjugates
   • Physiological substrates in the parasite remain unidentified
4. 2011 Medium

   Whether SENP1 activity matters for parasite viability was unresolved; pharmacological inhibition linked its enzymatic activity to intraerythrocytic replication and schizont egress, nominating it as a target for blood-stage growth and RBC exit.

   Evidence Aza-epoxide inhibitor screen (VEA-260) with in vitro protease inhibition, P. falciparum erythrocyte replication assays, and morphological analysis of infected RBCs

   PMID:21700207

   Open questions at the time

   • Target validation is pharmacological only, not genetic; inhibitor off-target effects not excluded
   • Egress and morphology phenotypes are correlative to inhibition, not to defined SENP1 substrates
   • No genetic knockout/knockdown phenotype established
5. 2016 Low

   Whether SENP1 has roles outside blood stages was unexplored; transcriptional upregulation in attenuated liver-stage sporozoites raised a possible stress/radiation-response role, though at the expression level only.

   Evidence Genome-wide microarray of γ-irradiation-attenuated intrahepatic P. falciparum sporozoites (day 3 post-infection)

   PMID:27911910

   Open questions at the time

   • Transcript-only observation with no protein-level or functional follow-up on SENP1
   • Causal link between SENP1 and stress response not tested
6. 2022 Low

   The subcellular context of SENP1 was undefined; proximity labeling of a nuclear pore scaffold placed it near the nuclear pore complex, hinting at a nuclear-envelope-associated context for its SUMO-processing activity.

   Evidence TurboID proximity labeling from P. berghei Nup313 followed by affinity purification and mass spectrometry

   PMID:36040030

   Open questions at the time

   • Proximity labeling does not establish direct interaction or stable localization
   • Shown in P. berghei, not confirmed for P. falciparum SENP1
   • Functional consequence of nuclear-pore proximity untested

• The endogenous SUMOylated substrates of SENP1, its genetic loss-of-function phenotype, and the structural basis of its distinct specificity remain unresolved in the available corpus.
• No native Plasmodium substrate identified
• No genetic knockout/knockdown phenotype
• No experimental structure despite crystallization feasibility